Free Trial

Burning Rock Biotech (BNR) Short Interest Ratio & Short Volume

Burning Rock Biotech logo
$2.71
-0.10 (-3.56%)
(As of 11/1/2024 ET)

Burning Rock Biotech Short Interest Data

Burning Rock Biotech (BNR) has a short interest of 120,300 shares, representing 1.42% of the float (the number of shares available for trading by the public). This marks a 183.06% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 13,221 shares to cover all short positions.

Current Short Interest
120,300 shares
Previous Short Interest
42,500 shares
Change Vs. Previous Month
+183.06%
Dollar Volume Sold Short
$347,667.00
Short Interest Ratio
4.4 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
10,240,000 shares
Float Size
8,490,000 shares
Short Percent of Float
1.42%
Today's Trading Volume
5,306 shares
Average Trading Volume
13,221 shares
Today's Volume Vs. Average
40%
Short Selling Burning Rock Biotech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Burning Rock Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BNR Short Interest Over Time

BNR Days to Cover Over Time

BNR Percentage of Float Shorted Over Time

Burning Rock Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024120,300 shares $347,667.00 +183.1%1.4%4.4 $2.89
9/30/202442,500 shares $138,975.00 +2.2%0.5%3.1 $3.27
9/15/202441,600 shares $148,512.00 +2.0%0.5%6.8 $3.57
8/31/202440,800 shares $216,036.00 +2.8%0.5%7.7 $5.30
8/15/202439,700 shares $247,728.00 -5.3%0.5%6.7 $6.24
7/31/202441,900 shares $308,384.00 +1.2%0.5%8.2 $7.36
7/15/202441,400 shares $298,080.00 +5.1%0.5%7 $7.20
6/30/202439,400 shares $254,019.68 -4.1%0.5%6.9 $6.45
6/15/202441,100 shares $316,881.00 +2.0%0.5%7.8 $7.71
5/31/202440,300 shares $311,519.00 -26.3%0.5%7.5 $7.73
5/15/202454,700 shares $440,335.00 -86.4%0.6%11.4 $8.05
4/30/2024402,400 shares $303,852.24 +1.1%0.5%7.8 $0.76
4/15/2024397,900 shares $318,320.00 -1.9%0.5%8.2 $0.80
3/31/2024405,400 shares $295,171.74 -1.2%0.5%6.2 $0.73
3/15/2024410,300 shares $279,004.00 +2.7%0.5%5.7 $0.68
2/29/2024399,500 shares $340,493.85 -0.5%0.5%5.5 $0.85
2/15/2024401,600 shares $325,296.00 -8.1%0.5%5.4 $0.81
1/31/2024437,000 shares $375,820.00 -25.0%0.5%6 $0.86
1/15/2024582,600 shares $541,818.00 +29.1%0.7%8.2 $0.93
12/31/2023451,300 shares $419,709.00 +2.8%0.5%8.1 $0.93
12/15/2023439,000 shares $329,381.70 -6.9%0.5%8.6 $0.75
11/30/2023471,600 shares $391,428.00 -0.9%0.6%7.9 $0.83
11/15/2023476,000 shares $448,439.60 -7.2%0.6%8.8 $0.94
10/31/2023512,700 shares $489,013.26 -6.7%0.6%9.9 $0.95
10/15/2023549,500 shares $560,490.00 -6.3%0.7%8.5 $1.02
9/30/2023586,700 shares $569,099.00 -6.4%0.7%9.1 $0.97
9/15/2023626,800 shares $626,800.00 +18.2%0.7%9.8 $1.00
8/31/2023530,500 shares $718,827.50 -7.6%0.6%8.9 $1.36
8/15/2023574,100 shares $866,891.00 -5.0%0.7%10.8 $1.51
7/31/2023604,500 shares $1.09 million -0.2%0.7%11.4 $1.80
7/15/2023605,600 shares $1.30 million -2.5%0.7%16.6 $2.14
6/30/2023621,000 shares $1.34 million -2.1%0.7%15.3 $2.15
6/15/2023634,400 shares $1.39 million -4.6%0.8%12.4 $2.19
5/31/2023665,100 shares $1.74 million +9.4%0.8%11.4 $2.61
5/15/2023608,200 shares $1.73 million -17.4%0.7%8.2 $2.85
4/30/2023736,000 shares $2.29 million -7.1%0.9%8.4 $3.11
4/15/2023791,900 shares $2.29 million -5.9%0.9%7.1 $2.89
3/31/2023841,100 shares $2.36 million +4.0%N/A6.5 $2.81
3/15/2023809,100 shares $2.40 million -17.4%N/A5.4 $2.97
2/28/2023979,200 shares $3.19 million -8.5%N/A5.5 $3.26
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

2/15/20231,070,000 shares $3.22 million -13.0%N/A5.5 $3.01
1/31/20231,230,000 shares $3.58 million -17.5%1.4%5.6 $2.91
1/15/20231,490,000 shares $5.04 million -6.3%1.7%6.6 $3.38
12/30/20221,590,000 shares $3.58 million -2.5%1.8%7 $2.25
12/15/20221,630,000 shares $4.52 million -11.9%1.9%6.2 $2.77
11/30/20221,850,000 shares $4.64 million -1.1%2.1%5.6 $2.51
11/15/20221,870,000 shares $4.26 million No Change2.2%5 $2.28
10/31/20221,870,000 shares $3.85 million -2.1%2.2%4.6 $2.06
10/15/20221,910,000 shares $4.13 million -1.6%2.2%4.5 $2.16
9/30/20221,940,000 shares $4.64 million +2.7%2.3%4.2 $2.39
9/15/20221,890,000 shares $6.24 million +18.9%2.2%3 $3.30
8/31/20221,590,000 shares $6.23 million +34.8%1.8%1.9 $3.92
8/15/20221,180,000 shares $4.65 million +18.3%1.4%1.5 $3.94
7/31/2022997,900 shares $3.18 million +9.7%1.2%1.2 $3.19
7/15/2022909,700 shares $2.90 million +70.9%1.1%1.1 $3.19
6/30/2022532,200 shares $1.55 million +39.2%0.6%0.7 $2.91
6/15/2022382,300 shares $791,361.00 -15.9%0.4%0.6 $2.07
5/31/2022454,600 shares $1.09 million -53.6%0.5%1.2 $2.40
5/15/2022980,500 shares $3.26 million -19.0%1.1%3.2 $3.32
4/30/20221,210,000 shares $6.67 million -4.0%1.4%4.7 $5.51
4/15/20221,260,000 shares $9.11 million -6.0%1.5%4.6 $7.23
3/31/20221,340,000 shares $12.45 million +3.9%1.6%4.8 $9.29
3/15/20221,290,000 shares $8.64 million +4.9%1.5%4.7 $6.70
2/28/20221,230,000 shares $10.37 million +5.1%1.4%4.3 $8.43
2/15/20221,170,000 shares $9.73 million +5.4%1.4%3 $8.32
1/31/20221,110,000 shares $9.99 million +4.7%1.3%2.7 $9.00
1/15/20221,060,000 shares $9.61 million +7.5%1.2%2.7 $9.07
12/31/2021986,000 shares $9.40 million +0.0%1.2%2.4 $9.53
12/15/2021985,700 shares $10.53 million -43.4%1.2%2.4 $10.68
11/30/20211,740,000 shares $26.90 million +4.8%2.0%4.8 $15.46
11/15/20211,660,000 shares $22.83 million -19.8%1.9%5.8 $13.75
10/29/20212,070,000 shares $29.17 million +9.0%2.4%8.6 $14.09
10/15/20211,900,000 shares $27.28 million +8.6%2.2%7.2 $14.36
9/30/20211,750,000 shares $31.29 million +31.6%2.1%7.2 $17.88
9/15/20211,330,000 shares $25.62 million +7.3%1.6%5.4 $19.26
8/31/20211,240,000 shares $23.10 million -0.8%1.5%5.1 $18.63
8/13/20211,250,000 shares $26.74 million -8.8%1.5%3.6 $21.39
7/30/20211,370,000 shares $31.21 million +8.7%1.6%3.6 $22.78
7/15/20211,260,000 shares $34.03 million -10.0%N/A3.6 $27.01
6/30/20211,400,000 shares $41.24 million -5.4%N/A3.8 $29.46
6/15/20211,480,000 shares $41.19 million +42.3%N/A3.8 $27.83
5/28/20211,040,000 shares $28.15 million +5.3%N/A2.6 $27.07
5/14/2021988,100 shares $28.51 million -31.4%1.1%2.8 $28.85
4/30/20211,440,000 shares $43.27 million -9.4%1.7%4.4 $30.05
4/15/20211,590,000 shares $48.50 million +62.5%1.8%4.4 $30.50
3/31/2021978,500 shares $24.73 million +4.6%1.1%2.4 $25.27
3/15/2021935,200 shares $25.33 million +131.7%N/A2.5 $27.09
2/26/2021403,600 shares $14.65 million +8.5%N/A1.2 $36.30
2/12/2021371,900 shares $12.67 million +0.6%0.4%1.2 $34.06
1/29/2021369,700 shares $10.93 million -5.2%0.4%1.4 $29.57
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

1/15/2021389,800 shares $10.72 million No Change0.5%1.7 $27.50

BNR Short Interest - Frequently Asked Questions

What is Burning Rock Biotech's current short interest?

Short interest is the volume of Burning Rock Biotech shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 120,300 shares of BNR short. 1.42% of Burning Rock Biotech's shares are currently sold short. Learn More on Burning Rock Biotech's current short interest.

What is a good short interest ratio for Burning Rock Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNR shares currently have a short interest ratio of 4.0. Learn More on Burning Rock Biotech's short interest ratio.

What is a good short interest percentage for Burning Rock Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.42% of Burning Rock Biotech's floating shares are currently sold short.

Is Burning Rock Biotech's short interest increasing or decreasing?

Burning Rock Biotech saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 120,300 shares, an increase of 183.1% from the previous total of 42,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Burning Rock Biotech's float size?

Burning Rock Biotech currently has issued a total of 10,240,000 shares. Some of Burning Rock Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Burning Rock Biotech currently has a public float of 8,490,000 shares.

How does Burning Rock Biotech's short interest compare to its competitors?

1.42% of Burning Rock Biotech's shares are currently sold short. Here is how the short interest of companies compare to Burning Rock Biotech: EUDA Health Holdings Limited (0.02%), Mangoceuticals, Inc. (1.63%), Enzo Biochem, Inc. (1.39%), Exagen Inc. (0.29%), Concord Medical Services Holdings Limited (0.48%), ATI Physical Therapy, Inc. (0.77%), The Oncology Institute, Inc. (0.76%), Renalytix Plc (0.46%), Psychemedics Co. (0.55%), Marpai, Inc. (0.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Burning Rock Biotech stock?

Short selling BNR is an investing strategy that aims to generate trading profit from Burning Rock Biotech as its price is falling. BNR shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Burning Rock Biotech?

A short squeeze for Burning Rock Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BNR, which in turn drives the price of the stock up even further.

How often is Burning Rock Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNR, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:BNR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners